rMal d 1 (a1454)

rMal d 1 (a1454)
Regulatory status
RUO
Application
FC (QC tested)
Variant
1 test
ED7671
In stock
4.00 USD
Variant
0.1 mg
11-261-C100
In stock
4.00 USD
Product details
Images
Application
FC (QC tested)
Description
Recombinant allergen is intended for in vitro stimulation of basophilic granulocytes, which is IgE-mediated on cellular level, to determine a measure of basophil activation by means of flow cytometry (BAT) in human whole blood sample.
Contents
Reagent is provided as the freeze-dried mixture of the recombinant allergen and protective excipients in single-use test tube for flow cytometry. The reagent is for single use only.
Preparation
The allergen is provided in lyophilized form.
Storage and handling
Store the product at 20-30°C. Expiration is stated on the label.
ED7671_FC_Histogram
Left: Negative control sample. Basophils of non-stimulated human peripheral whole blood of a proven allergic donor in the presence of stimulation buffer stained using anti-human CD63 (MEM-259) FITC and anti-human CD203c (NP4D6) PE antibodies of BasoFlowEx kit.
Right: Allergen-stimulated sample. Separation of CD63 positive basophils (79,4 %) from CD63 negative basophils (20,6 %) in flow cytometry analysis (surface staining) of rMal d 1 recombinant allergen stimulated human peripheral whole blood of a proven allergic donor stained using anti-human CD63 (MEM-259) FITC and anti-human CD203c (NP4D6) PE antibodies of BasoFlowEx kit.
Variant
1 test
ED7671
In stock
4.00 USD
Variant
0.1 mg
11-261-C100
In stock
4.00 USD

Related products

-134%
Reg. statusCE IVD
ApplicationFC
100 tests
560.00 USD
-134%
Reg. statusRUO
ApplicationFC
1 test
2.75 USD